Yatin Suneja
Stock Analyst at Guggenheim
(2.24)
# 2,676
Out of 4,761 analysts
112
Total ratings
44.79%
Success rate
-4.66%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences | Maintains: Buy | $165 → $163 | $120.69 | +35.06% | 4 | Feb 10, 2025 | |
| IMVT Immunovant | Maintains: Buy | $46 → $44 | $21.27 | +106.86% | 6 | Feb 10, 2025 | |
| VIGL Vigil Neuroscience | Reiterates: Buy | n/a | $3.03 | - | 3 | Jan 24, 2025 | |
| SRZN Surrozen | Upgrades: Buy | $45 | $11.20 | +301.79% | 3 | Jan 3, 2025 | |
| ACAD ACADIA Pharmaceuticals | Downgrades: Neutral | $20 | $19.95 | +0.25% | 6 | Jan 3, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $90 → $36 | $18.59 | +93.65% | 11 | Dec 12, 2024 | |
| QTTB Q32 Bio | Downgrades: Neutral | n/a | $2.57 | - | 2 | Dec 12, 2024 | |
| TRML Tourmaline Bio | Reiterates: Buy | n/a | $12.21 | - | 2 | Dec 11, 2024 | |
| ZBIO Zenas BioPharma | Reiterates: Buy | n/a | $7.83 | - | 2 | Dec 3, 2024 | |
| ARGX argenx SE | Maintains: Buy | $585 → $665 | $644.48 | +3.18% | 8 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $21.29 | +205.31% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $170 | $74.49 | +128.22% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,180 → $1,300 | $700.33 | +85.63% | 5 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $5.17 | +518.96% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.25 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $8.08 | +518.81% | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $22.46 | +300.71% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $137.75 | -9.26% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $10.68 | +49.81% | 2 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $77 | $42.33 | +81.90% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $1.80 | +1,122.22% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $2.06 | +1,550.49% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.13 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $1.40 | +1,328.57% | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $39.73 | +23.33% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $6.15 | +794.31% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $3.19 | +338.87% | 3 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $140.64 | +148.86% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.83 | - | 4 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.31 | - | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $30 | $5.67 | +429.10% | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.30 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $15.75 | +52.38% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $67.96 | -49.97% | 2 | Jan 14, 2020 |
Neurocrine Biosciences
Feb 10, 2025
Maintains: Buy
Price Target: $165 → $163
Current: $120.69
Upside: +35.06%
Immunovant
Feb 10, 2025
Maintains: Buy
Price Target: $46 → $44
Current: $21.27
Upside: +106.86%
Vigil Neuroscience
Jan 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $3.03
Upside: -
Surrozen
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $11.20
Upside: +301.79%
ACADIA Pharmaceuticals
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $19.95
Upside: +0.25%
AnaptysBio
Dec 12, 2024
Maintains: Buy
Price Target: $90 → $36
Current: $18.59
Upside: +93.65%
Q32 Bio
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.57
Upside: -
Tourmaline Bio
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $12.21
Upside: -
Zenas BioPharma
Dec 3, 2024
Reiterates: Buy
Price Target: n/a
Current: $7.83
Upside: -
argenx SE
Nov 1, 2024
Maintains: Buy
Price Target: $585 → $665
Current: $644.48
Upside: +3.18%
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $21.29
Upside: +205.31%
Aug 14, 2024
Maintains: Buy
Price Target: $155 → $170
Current: $74.49
Upside: +128.22%
Aug 2, 2024
Maintains: Buy
Price Target: $1,180 → $1,300
Current: $700.33
Upside: +85.63%
Jul 23, 2024
Initiates: Buy
Price Target: $32
Current: $5.17
Upside: +518.96%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.25
Upside: -
Apr 29, 2024
Initiates: Buy
Price Target: $50
Current: $8.08
Upside: +518.81%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $22.46
Upside: +300.71%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $137.75
Upside: -9.26%
Nov 15, 2023
Maintains: Buy
Price Target: $17 → $16
Current: $10.68
Upside: +49.81%
Nov 15, 2023
Maintains: Buy
Price Target: $70 → $77
Current: $42.33
Upside: +81.90%
Oct 10, 2023
Initiates: Buy
Price Target: $22
Current: $1.80
Upside: +1,122.22%
Aug 14, 2023
Reiterates: Buy
Price Target: $34
Current: $2.06
Upside: +1,550.49%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.13
Upside: -
Jun 22, 2023
Initiates: Buy
Price Target: $20
Current: $1.40
Upside: +1,328.57%
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $39.73
Upside: +23.33%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $6.15
Upside: +794.31%
May 17, 2023
Maintains: Buy
Price Target: $12 → $14
Current: $3.19
Upside: +338.87%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $140.64
Upside: +148.86%
Apr 6, 2023
Upgrades: Buy
Price Target: n/a
Current: $1.83
Upside: -
Jan 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $7.31
Upside: -
Nov 11, 2022
Maintains: Buy
Price Target: $42 → $30
Current: $5.67
Upside: +429.10%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.30
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $15.75
Upside: +52.38%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $67.96
Upside: -49.97%